2018
DOI: 10.1021/jacs.8b03442
|View full text |Cite
|
Sign up to set email alerts
|

Supramolecularly Engineered Circular Bivalent Aptamer for Enhanced Functional Protein Delivery

Abstract: Circular bivalent aptamers (cb-apt) comprise an emerging class of chemically engineered aptamers with substantially improved stability and molecular recognition ability. Its therapeutic application, however, is challenged by the lack of functional modules to control the interactions of cb-apt with therapeutics. We present the design of a β-cyclodextrin-modified cb-apt (cb-apt-βCD) and its supramolecular interaction with molecular therapeutics via host-guest chemistry for targeted intracellular delivery. The su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
65
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 98 publications
(67 citation statements)
references
References 33 publications
(54 reference statements)
0
65
0
Order By: Relevance
“…These chemical cyclisation methods offer several advantages over the more limited enzymatic approach: they are cheaper and easier to carry out, allowing for the large-scale synthesis and purification of the cyclic oligonucleotide products; they can also be performed under a wider variety of conditions, including denaturing ones, and are therefore particularly useful for cyclising linear oligonucleotides which contain problematic secondary structure. The chemical cyclisation methods described here therefore provide a versatile expanded toolkit for the preparation of cyclic oligonucleotides, which have an expansive range of potential applications across molecular biology 61 65 and nanotechnology. 66 69 Here we investigated the use of the chemically modified cyclic products as templates for the production of long single-stranded DNA concatemers via the highly demanding rolling circle amplification reaction, an important technique which is currently attracting widespread interest.…”
Section: Discussionmentioning
confidence: 99%
“…These chemical cyclisation methods offer several advantages over the more limited enzymatic approach: they are cheaper and easier to carry out, allowing for the large-scale synthesis and purification of the cyclic oligonucleotide products; they can also be performed under a wider variety of conditions, including denaturing ones, and are therefore particularly useful for cyclising linear oligonucleotides which contain problematic secondary structure. The chemical cyclisation methods described here therefore provide a versatile expanded toolkit for the preparation of cyclic oligonucleotides, which have an expansive range of potential applications across molecular biology 61 65 and nanotechnology. 66 69 Here we investigated the use of the chemically modified cyclic products as templates for the production of long single-stranded DNA concatemers via the highly demanding rolling circle amplification reaction, an important technique which is currently attracting widespread interest.…”
Section: Discussionmentioning
confidence: 99%
“…123 Some recent case studies of the CDs in the optimal drug delivery of drugs, proteins, peptides and aptamers are reported in the Table 3. [124][125][126][127][128][129][130][131][132][133][134][135][136][137][138][139][140] CDs can be moulded into various types of formulation for proving ease the drug delivery by diverse routes of administration.…”
Section: An Account Of Recent Advances In Cds For Optimal Drug Deliverymentioning
confidence: 99%
“…The obtained circular bivalent aptamers were applied for in vivo fluorescence imaging, which validates their efficient accumulation and retention in tumors. When the circular bivalent aptamers were labeled with β‐cyclodextrin, they can be efficiently loaded with functional protein via host‐guest chemistry for therapeutic applications (Figure B) . Recently, Jia et al.…”
Section: Circular Functional Nucleic Acidsmentioning
confidence: 99%